DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Biosimilars

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

News

Merck Millipore, Celares, to Offer Pegylation Services

06.10.2015 - Merck Millipore, the life science business of Germany’s Merck, plans to collaborate with compatriot Celares, a drug delivery company providing customized solutions, to offer...

Strategy & Management

Significant Value Creation

03.09.2015 - In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...

News

FDA Releases Naming Rules for Biosimilars

31.08.2015 - The US Food and Drug Administration has released a proposal for naming biosimilars – lower-cost biotech drugs – almost simultaneously with the market launch of the first such...

News

EU Approves Pfizer-Hospira Deal With Strings

06.08.2015 - European regulatory authorities have approved the $15.2 billion takeover of injectable drug and infusion device maker Hospira by US drugmaker Pfizer, subject to certain conditions...

News

Novartis Can Sell Neupogen Copy in US in September

24.07.2015 - A US federal appeals court has ruled that Swiss drugmaker Novartis can begin selling Zarxio, its lower-cost generic version of an Amgen drug, on the US market starting in September...

News

Sartorius Stedim Biotech Buys BioOutsource

20.04.2015 - French biopharmaceutical industry contract supplier Sartorius Stedim Biotech (SSM) has acquired BioSource, a privately owned Glasgow, Scotland-based biotech firm for an undisclosed...

News

FDA Approves the First-Ever US Biosimilar

16.03.2015 - The US Food & Drug Administration has approved the country's first biosimilar product, a move observers say will open the door for lower cost, generic-like biological drugs. The...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.